APP and Alzheimer disease: In our results, NTN-1 was found to decrease CSF Aβ level, increase sAPPα production, FL APP cleavage and induce microglia from M1 to M2 polarization, thereby preventing Aβ aggregates in AD rats and might be a result of alterations in neuroinflammatory impairment.